Corcept Therapeutics

+$0.56 (+2.66%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol.

CEO
Joseph K. Belanoff
Employees
236
Headquarters
Menlo Park, California
Founded
1998

CORT Key Statistics

Market Cap
2.61B
Price-Earnings Ratio
27.04
Dividend Yield
—
Average Volume
654.63K
High Today
$21.65
Low Today
$20.87
Open Price
$21.01
Volume
674.10K
52 Week High
$31.18
52 Week Low
$12.20

CORT News

Simply Wall StJul 28

Corcept Therapeutics Incorporated's Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at Corcept Therapeutics' (NASDAQ:CORT) recent performance, when its stock has declined 16% over the past three months. H

CORT Earnings

$0.16
$0.22
$0.28
$0.34
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.16 per share
Actual
$0.30 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure